chrX-49317196-T-A
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_001098413.4(GAGE10):c.236T>A(p.Val79Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000128 in 1,093,292 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 6 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001098413.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GAGE10 | NM_001098413.4 | c.236T>A | p.Val79Asp | missense_variant | 4/5 | ENST00000407599.4 | NP_001091883.3 | |
GAGE10 | XM_024452325.1 | c.194T>A | p.Val65Asp | missense_variant | 2/3 | XP_024308093.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GAGE10 | ENST00000407599.4 | c.236T>A | p.Val79Asp | missense_variant | 4/5 | 5 | NM_001098413.4 | ENSP00000385415.3 |
Frequencies
GnomAD3 genomes Cov.: 22
GnomAD3 exomes AF: 0.0000109 AC: 2AN: 183283Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 67761
GnomAD4 exome AF: 0.0000128 AC: 14AN: 1093292Hom.: 0 Cov.: 30 AF XY: 0.0000167 AC XY: 6AN XY: 359370
GnomAD4 genome Cov.: 22
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 04, 2024 | The c.236T>A (p.V79D) alteration is located in exon 4 (coding exon 3) of the GAGE10 gene. This alteration results from a T to A substitution at nucleotide position 236, causing the valine (V) at amino acid position 79 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at